Pfizer Inc. v. Government of India, 434 U.S. 308 (1978) decision of the Supreme Court of the United States in which the Court held that foreign states are entitled to sue for treble damages in U.S. courts, and should be recognized as "persons" under the Clayton Act.
Parties, docket activity and news coverage of federal case American Sales Company, LLC v. Pfizer, Inc. et al, case number 2:14-cv-00361, from Virginia Eastern Court.
Court of Appeal, First District, Division 2, California. James CLAYWORTH, et al., Plaintiffs and Appellants, v. PFIZER, INC., et al., Defendants and Respondents. No. A116798. Decided: July 25, 2008. Alioto Law Firm, Joseph M. Alioto, Theresa D. Moore, Angelina Alioto-Grace, Joseph M. Alioto, Jr., Thomas P. Pier, San ...
Niewerth et al. (9) compared the agar macrodilution and broth microdilution methods, demonstrating consistently lower MICs with the microdilution method. .... The Center for Medical Mycology thanks Dermik Laboratories, Pfizer, Inc., and Schering-Plough Research Institute for their generous support of this study. Go to : ...
In keeping with data from these separate studies, it is worth noting that Sofia and colleagues (Sofia et al.,1971) similarly suggested that the diuretic actions of oral ... WIN-55-212 were purchased from Tocris Bioscience (Ellisville, MO), and U50, 488 was obtained from the Upjohn Company (Kalamazoo, MI; now Pfizer Inc.).
In a comprehensive postmortem MS study, Kutzelnigg et al. showed that, with progression of disease, WM abnormalities change from predominantly focal and ..... Dr. Benedict serves on scientific advisory boards for Merck Serono, Biogen Idec, Bayer Schering Pharma, Novartis, and Pfizer Inc.; serves on the editorial boards ...
Jul 25, 2008 ... Aminocandin (IP-960, Indevus) and caspofungin (Merck & Co., Inc., Whitehouse Station, NJ, USA) stock solutions were prepared in sterile water and .... by a susceptible C. glabrata isolate, Gumbo et al. demonstrated that a single high dose of micafungin 100 mg/kg was effective in reducing fungal burden.
Jan 22, 2008 ... The voriconazole global clinical trials database (Pfizer), consisting of demographic, clinical, and microbiological details of over 2,000 patients, was queried ..... survival times in solid organ transplant recipients than in patients who were otherwise immunosuppressed, adding to the experience of Husain et al.
A single lot of each of the four liquid medium formulations was provided ready-to- use to all participants by Trek Diagnostic Systems Inc. (Westlake, Ohio). ..... Arikan et al. (3) reported that buffered (phosphate) M3-2% had a tendency to yield lower MICs of amphotericin B, itraconazole and voriconazole than those obtained ...